Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Active Controlled, Double-blind, Multi-Centre Study to Evaluate Safety and Immunogenicity of One Dose of FLUVAL AB-like (Trivalent, Whole Virus, Aluminium Phosphate Gel Adjuvanted) Influenza Vaccine Containing 6μgHA of Seasonal A/H1N1, A/H3N2 and B Influenza Antigens in Non-elderly Adult and Elderly Subjects

NCT01459276 is registered in ClinicalTrials.gov with Fluart Innovative Vaccine Ltd, Hungary as lead sponsor.

NCT NCT01459276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01459276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Active Controlled, Double-blind, Multi-Centre Study to Evaluate Safety and Immunogenicity of One Dose of FLUVAL AB-like (Trivalent, Whole Virus, Aluminium Phosphate Gel Adjuvanted) Influenza Vaccine Containing 6μgHA of Seasonal A/H1N1, A/H3N2 and B Influenza Antigens in Non-elderly Adult and Elderly Subjects
Lead sponsor
Fluart Innovative Vaccine Ltd, Hungary
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2011
Completion date
March 31, 2012
Enrollment
1,206 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

influenza